JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Net Income From Continuing Operations : ฿46.2 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. JSP Pharmaceutical Manufacturing (Thailand) PCL's net income from continuing operations for the three months ended in Sep. 2024 was ฿31.7 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was ฿46.2 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Income From Continuing Operations Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Income From Continuing Operations Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

23.57

31.08

29.69

-3.07

28.24

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income From Continuing Operations	Get a 7-Day Free Trial												35.15	4.27	-3.32	13.56	31.73

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿46.2 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

JSP-R:Thailand

Address

No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120

Website

https://www.jsppharma.com

JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name; Manufacture and distribution of hemodialysis solution and related medical supplies and Service, research and development, and healthcare products training. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL Headlines

No Headlines